
Daniel Myran
Dr. Daniel Myran is a family, public health, and preventative medicine physician and researcher at the University of Ottawa in Ontario. He is known for his research into the real-world effects of psychedelics, particularly focusing on the risks associated with adverse reactions to hallucinogens, as highlighted in a recent study he led that found a significant increase in mortality risk following bad psychedelic trips.
Country presence
Recent news mentions
Daniel Myran is a physician from the Ottawa Hospital Research Institute who studies the effects of cannabis legalization.
Das weiss man über die GefahrenDaniel Myran is an associate professor at the University of Toronto and a co-author of the study.
Ontario helpline saw increase in gambling-related requests after province opened regulated market, study finds
Daniel Myran is a family physician and ICES scientist who co-authored the study on ADHD prescriptions.
Stimulant prescriptions for ADHD up sharply since 2015, especially among womenDaniel Myran is a researcher at the Bruyère Health Research Institute in Ottawa who studies cannabis-related health issues.
Número de usuários idosos de cannabis está crescendo. E o risco também, dizem especialistasDr. Daniel Myran is a coauthor of the study linking cannabis use to an increased risk of dementia.
Marijuana hospital visits linked to dementia diagnosis within 5 years, study finds
Daniel Myran is the study’s senior author and a family physician at Ottawa Hospital.
Dozens of illegal magic mushroom dispensaries operating in major Canadian cities with no guardrails: studyDr. Daniel Myran is the lead study author who researched the risks associated with bad psychedelic trips.
Psychedelic trips can go bad. That may have serious consequences, study says











